Unexplained weight loss (UWL) is a clinical conundrum that often presents a diagnostic challenge to physicians. It can be an indicator of a serious underlying condition, necessitating a comprehensive, systematic approach to accurately determine its etiology.
The first step in diagnosing UWL is a thorough history taking. This includes the patient's past medical history, lifestyle habits, medications, and psychosocial factors. A detailed dietary history can reveal potential causes such as malnutrition or malabsorption. The duration and rate of weight loss can also provide valuable clues.
A comprehensive physical examination is crucial to identify any abnormal findings suggestive of a specific disease. Basic investigations include complete blood counts, kidney and liver function tests, thyroid function tests, and a urinalysis. These can help rule out common causes of UWL like malignancies, endocrine disorders, and chronic infections.
If the initial investigations are inconclusive, further diagnostic testing may be warranted. This may include imaging studies, endoscopies, or biopsies, depending on the patient's symptoms and history. A multidisciplinary approach involving specialists such as gastroenterologists, endocrinologists, or oncologists may be necessary in complex cases.
It's important to consider non-organic causes of UWL, such as psychiatric disorders including depression and eating disorders. A psychiatric evaluation may be beneficial in these cases. Social factors, such as food insecurity or elder neglect, should also be considered.
Diagnosing UWL requires a systematic, comprehensive approach that includes a detailed history, physical examination, and appropriate investigations. Collaboration with specialists may be necessary. Understanding and identifying the cause of UWL is vital as it can be a sign of a serious underlying condition, warranting prompt treatment.
1.
High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy
2.
Papillary thyroid cancer: New markers offer hope for tailored treatment
3.
What Comes After Cancer?
4.
FDA Expands Durvalumab Label to Operable Lung Cancer
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Finding Support: Connecting with the Vitiligo Community
2.
Essential Updates in Hematology in Daily Practice
3.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
4.
Living Better With Advanced Cancer Through Supportive Care
5.
Understanding Epoetin and Its Role in Treating Chronic Kidney Disease
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
2.
Updates on Standard V/S High Risk Myeloma Treatment
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation